D. Kikelj

4.2k total citations
158 papers, 3.4k citations indexed

About

D. Kikelj is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, D. Kikelj has authored 158 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Molecular Biology, 88 papers in Organic Chemistry and 23 papers in Toxicology. Recurrent topics in D. Kikelj's work include Cancer therapeutics and mechanisms (34 papers), Bioactive Compounds and Antitumor Agents (23 papers) and Chemical Synthesis and Analysis (23 papers). D. Kikelj is often cited by papers focused on Cancer therapeutics and mechanisms (34 papers), Bioactive Compounds and Antitumor Agents (23 papers) and Chemical Synthesis and Analysis (23 papers). D. Kikelj collaborates with scholars based in Slovenia, Finland and France. D. Kikelj's co-authors include Janez Ilaš, Lucíja Peterlin Mašič, Tihomir Tomašič, Nace Zidar, Päivi Tammela, Marko Anderluh, Marija Sollner Dolenc, Michaela Barančoková, Žiga Skok and Stanislav Gobec and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

D. Kikelj

154 papers receiving 3.3k citations

Peers

Countries citing papers authored by D. Kikelj

Since Specialization

Citations

This map shows the geographic impact of D. Kikelj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Kikelj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Kikelj more than expected).

Fields of papers citing papers by D. Kikelj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Kikelj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Kikelj. The network helps show where D. Kikelj may publish in the future.

Co-authorship network of co-authors of D. Kikelj

This figure shows the co-authorship network connecting the top 25 collaborators of D. Kikelj. A scholar is included among the top collaborators of D. Kikelj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Kikelj. D. Kikelj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New ATP-competitive inhibitors of E. coli GyrB obtained from the mapping of the hydrophobic floor at the binding site: synthesis and biological evaluation 2024 ·RSC Medicinal Chemistry ·Lucas Gutiérrez, (unknown), (unknown), Nace Zidar, D. Kikelj, Ricardo D. Enriz	1
2	Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study 2024 ·Bioorganic & Medicinal Chemistry ·Nace Zidar, Andrej Emanuel Cotman, (unknown), Ondřej Benek, Michaela Barančoková, Anamarija Zega, Lucíja Peterlin Mašič, Tihomir Tomašič, Janez Ilaš, (unknown), (unknown), Anthony Maxwell, Clare E. M. Stevenson, David M. Lawson, Geert Jan Sterk, (unknown), Lucas Gutiérrez, Ricardo D. Enriz, D. Kikelj	2
3	New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity 2024 ·RSC Advances ·Andrej Emanuel Cotman, (unknown), (unknown), (unknown), Davide Benedetto Tiz, Žiga Skok, Martina Durcik, (unknown), (unknown), Cristina D. Cruz, Päivi Tammela, Petra Szili, Lejla Daruka, Csaba Pál, Anamarija Zega, Lucíja Peterlin Mašič, Janez Ilaš, Tihomir Tomašič, D. Kikelj, Nace Zidar	1
4	Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria 2024 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Martina Durcik, (unknown), Petra Szili, Márton Simon Czikkely, Nace Zidar, (unknown), Csaba Pál, Tomaž Accetto, Luis A. Pardo, D. Kikelj, Lucíja Peterlin Mašič, Tihomir Tomašič, Wilbert Bitter, Andrej Emanuel Cotman, Alexander Speer, Anamarija Zega	3
5	Practical Synthesis and Application of Halogen-Doped Pyrrole Building Blocks 2021 ·ACS Omega ·Andrej Emanuel Cotman, (unknown), (unknown), Davide Benedetto Tiz, Martina Durcik, (unknown), (unknown), (unknown), (unknown), Janez Ilaš, Anamarija Zega, Nace Zidar, Lucíja Peterlin Mašič, Tihomir Tomašič, Frédéric R. Leroux, Gilles Hanquet, D. Kikelj	8
6	Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1H-indoles 2020 ·ACS Medicinal Chemistry Letters ·Nace Zidar, (unknown), Tihomir Tomašič, Lucíja Peterlin Mašič, D. Kikelj, Daniele Passarella, (unknown), (unknown), Lisa Dalla Via	23
7	Efficient Synthesis of Hydroxy-Substituted 2-Aminobenzo[d]thiazole-6-carboxylic Acid Derivatives as New Building Blocks in Drug Discovery 2020 ·ACS Omega ·Martina Durcik, (unknown), Nace Zidar, Janez Ilaš, Anamarija Zega, D. Kikelj, Lucíja Peterlin Mašič, Tihomir Tomašič	11
8	Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors 2020 ·ACS Medicinal Chemistry Letters ·Žiga Skok, Michaela Barančoková, Ondřej Benek, Cristina D. Cruz, Päivi Tammela, Tihomir Tomašič, Nace Zidar, Lucíja Peterlin Mašič, Anamarija Zega, Clare E. M. Stevenson, (unknown), David M. Lawson, Anthony Maxwell, D. Kikelj, Janez Ilaš	34
9	Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation 2020 ·Pharmaceutics ·Martina Durcik, Žiga Skok, Janez Ilaš, Nace Zidar, Anamarija Zega, Petra Szili, Gábor Draskovits, Tamás Révész, D. Kikelj, Ákos Nyerges, Csaba Pál, Lucíja Peterlin Mašič, Tihomir Tomašič	13
10	An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors 2019 ·European Journal of Medicinal Chemistry ·Davide Benedetto Tiz, Žiga Skok, Martina Durcik, Tihomir Tomašič, Lucíja Peterlin Mašič, Janez Ilaš, Anamarija Zega, Gábor Draskovits, Tamás Révész, Ákos Nyerges, Csaba Pál, Cristina D. Cruz, Päivi Tammela, Dušan Žigon, D. Kikelj, Nace Zidar	42
11	New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors 2019 ·MedChemComm ·Nace Zidar, (unknown), Tihomir Tomašič, Lucíja Peterlin Mašič, Janez Ilaš, Anamarija Zega, Päivi Tammela, D. Kikelj	13
12	Design, synthesis and biological evaluation of novel DNA gyrase inhibitors and their siderophore mimic conjugates 2019 ·Bioorganic Chemistry ·(unknown), Cristina D. Cruz, Žiga Skok, Michaela Barančoková, Nace Zidar, Anamarija Zega, Lucíja Peterlin Mašič, Janez Ilaš, Päivi Tammela, D. Kikelj, Tihomir Tomašič	14
13	New N -phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity 2018 ·European Journal of Medicinal Chemistry ·Martina Durcik, (unknown), Žiga Skok, Cristina D. Cruz, Päivi Tammela, Tihomir Tomašič, Davide Benedetto Tiz, Gábor Draskovits, Ákos Nyerges, Csaba Pál, Janez Ilaš, Lucíja Peterlin Mašič, D. Kikelj, Nace Zidar	32
14	Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7‐Tetrahydrobenzo[1,2‐d]thiazole Derivatives 2018 ·ChemMedChem ·(unknown), Tihomir Tomašič, Philipp Schult, Volker Lohmann, D. Kikelj, Päivi Tammela	6
15	Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors 2018 ·ACS Medicinal Chemistry Letters ·(unknown), Tihomir Tomašič, D. Mariano A. Vera, (unknown), (unknown), (unknown), Žiga Hodnik, Lucíja Peterlin Mašič, D. Kikelj, Marı́a C. Carpinella	12
16	Benzothiazole-based Compounds in Antibacterial Drug Discovery 2017 ·Current Medicinal Chemistry ·(unknown), Tihomir Tomašič, D. Kikelj, Lucíja Peterlin Mašič	57
17	Design, synthesis, and biological evaluation of 1‐ethyl‐3‐(thiazol‐2‐yl)urea derivatives as Escherichia coli DNA gyrase inhibitors 2017 ·Archiv der Pharmazie ·Tihomir Tomašič, Michaela Barančoková, Nace Zidar, Janez Ilaš, Päivi Tammela, D. Kikelj	15
18	Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening 2016 ·Assay and Drug Development Technologies ·Marc Rogers, Nace Zidar, D. Kikelj, (unknown)	20
19	Convergent domino Knoevenagel hetero-Diels-Alder and domino oxidation reactions revealed in an unexpected synthesis of 5-Aryl-1H-pyrano[2,3-d]pyrimidine-2,4(3H,5H)-diones and 5-Aryl-2-thioxo-2,3-dihydro-1H-pyrano[2,3-d]pyrimidin-4(5H)-ones 2011 ·Helvetica Chimica Acta ·Nace Zidar, D. Kikelj	2
20	Recent Advances in the Discovery of Tissue Factor/Factor VIIa Inhibitors and Dual Inhibitors of Factor VIIa/Factor Xa 2005 ·Current Pharmaceutical Design ·(unknown), D. Kikelj, Lucíja Peterlin Mašič	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact